• Agreement on the distribution of medicine costs due to payment difficulties  

• Supplementary agreement on further distribution of pharmaceutical costs  

General 

• General guidelines - Updated 01.03.2022 

• Deviation from reference price - Updated 15.02.2025 

• Transplanted organs - working principle and medication list - Updated 01.07.2021 

• Cancer and aftercare – Class I - Updated 01.10.2021 

• Palliative care at home for cancer – Class III – Updated 01.01.2021 

• Palliative care at home – Category III - Updated 01.01.2021 

• Kidney failure - Updated 01.03.2022 

• Lipid-lowering drugs - Updated 01.10.2022 

• Blood pressure medication - Updated 01.01.2023 

• Entresto - Updated 01.02.2024 

• Kerendia - New document 01.01.2024 

• Procoralan - Updated 01.07.2021 

• Visanne - Updated 01.04.2022 

• Aldara - Updated 01.10.2020 

• Emollient and skin-protecting cream - Updated 01.07.2021 

• Solaraze - Updated 01.04.2022 

• Toctino - Updated 01.04.2022

• Laxatives - Updated 10.11.2016 

• Calcium - Updated 01.05.2022 

• Plenadren - Updated 01.11.2020 

• Antidiabetic drugs - Updated 01.09.2024 

• Vitamins - Updated 01.05.2022 

• Wegovy - Updated 01.11.2023 

• Antibiotics and Fungicides - Updated 01.04.2022 

• Amphetamines - Updated 01.09.2024 

• Atomoxetine - Updated 01.09.2024 

• Dexamfetamine - Updated 01.09.2024 

• Fampyra - Updated 01.06.2022 

• Antipsychotics - Updated 01.02.2022 

• Heminevrin - Updated 01.07.2021 

• Intuniv - Updated 01.10.2020 

• Lisdexamfetamine - Updated 01.09.2024 

• Melatonin - Updated 01.01.2024 

• Methylphenidate - Updated 01.03.2025 

• Migraine medication - Updated 01.10.2024 

• Modafinil - Updated 01.02.2020 

• Pregabalin - Updated 01.07.2022 

• Slenyto - New document 01.11.2021 

• Qutenza® patch and Capsina cream - Updated 01.09.2022 

• Painkillers - Updated 01.09.2022 

• Antidepressants - Updated 01.11.2022 

• Bone density drugs - Updated 28.01.2023 

• Colestyramine - Updated 01.09.2022 

• Efudix - Updated 01.07.2021 

• Febuxostat - Updated 28.11.2019 

• Grasax - Updated 01.07.2021 

• Pneumovax and Prevenar 13 - Updated 28.01.2023 

• Quinine Sulfate - Uppfært 01.05.2022 

• Hormonal IUD - Updated 01.04.2024 

• Sildenafil and tadalafil - Updated 01.05.2022 

• Yentreve - Updated 01.05.2022 

• Contraceptives - Updated 01.04.2021 

• The Icelandic Medicines Act No. 100/2020 – Effective from 1 January 2021  

• Act on Health Security and Communicable Diseases No. 19/1997 

• Regulation on Iceland Health Payment participation of Pharmaceutical Costs No. 1143/2019 

• Regulation on Reimbursement of Significant Expenses of Health Insured Persons for Medical Care, Medicines and Training, No. 355/2005 

• Regulation on Prescriptions and Supply of Medicinal Products No. 740/2020 

• Regulation on Addictive Substances and Other Controlled Substances No. 233/2001 

• Regulation on Dentists' Authorisation to Prescribe Medicinal Products No. 477/2019 

• Regulation on the Dosage of Medicinal Products No. 850/2002 

• Regulation on Reporting of Communicable Diseases No. 221/2012 

• Regulation on communicable disease prevention measures no. 817/2012 

• Rules on the breakdown of the price of medicinal products sold on prescription no. 384/2007